Varubi (Tesaro, Inc.)


Welcome to the PulseAid listing for the Varubi drug offered from Tesaro, Inc.. This Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Tesaro, Inc.
NON-PROPRIETARY NAME: rolapitant
SUBSTANCE NAME: ROLAPITANT
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, EMULSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-10-25
END MARKETING DATE: 0000-00-00


Varubi HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVarubi from Tesaro, Inc.
LABELER NAME: Tesaro, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.8(mg/mL)
START MARKETING DATE: 2017-10-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69656-102_155e4cf0-6ad7-49ee-b6ab-dd5caeec578c
PRODUCT NDC: 69656-102
APPLICATION NUMBER: NDA208399

Other ROLAPITANT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Tesaro, Inc.Varubi